cross-reactivity with strains of FIPV, feline enteric coronavirus, canine coronavirus, and porcine transmissible gastroenteritis virus. Nineteen S-specific MAbs neutralized FIPV. A total of 15 of the neutralizing MAbs induced ADE, and ali but 1 were of the immunoglobulin G2a subclass. The remaining four neutralizing MAbs that did not induce ADE were of the immunoglobulin Gl subclass. Two S-specific MAbs induced ADE but were nonneutralizing. None of the N-or M-specific MAbs was neutralizing or induced ADE. On the basis of the reactivity patterns of the MAbs with FIPV and related coronaviruses, it was concluded that there is a minimum of five neutralizing sites on S. In most instances, neutralizing MAbs were able to induce ADE, demonstrating a direct relationship between neutralization and enhancement. The difference in immunoglobulin subclass between neutralizing MAbs that induced ADE and those that did not induce ADE suggests that there may be a restriction in the immunoglobulin subclasses capable of mediating ADE.
Feline infectious peritonitis virus (FIPV), a positivestranded and enveloped RNA virus, is a member of the genus Coronavirus in the family Coronaviridae. It causes a complex and invariably fatal disease in cats known as feline infectious peritonitis (FIP), with lesions characterized by fibrinonecrotic and pyogranulomatous peritonitis and pleuritis (35, 52, 54, 55) . Although natural exposure of cats to FIPV or related coronaviruses appears to occur with a high degree of frequency, only a small percentage of cats develop FIP. The presence of antibodies to FIPV in a large percentage of healthy cats suggests that most natural infections are subclinical. Serologic studies have demonstrated the presence of antibody to FIPV in more than 80% of cats raised in catteries (24, 28, 36) , but even under these conditions the incidence of disease rarely exceeds 10% of the population (35, 36) . In contrast, experimental infection of specificpathogen-free cats with virulent strains of FIPV most often results in death. In spite of the relatively low incidence of FIP resulting from natural infection, FIP remains a serious problem for which there is no effective treatment.
Immunity to FIPV is poorly understood and is dependent on factors seemingly unrelated or indirectly related to antibody titer. Cats with naturally occurring virus-neutralizing antibody to FIPV frequently develop FIP more rapidly and with more severe clinical signs than do seronegative cats following experimental infection (39, 52) . The unique role of antibody in promoting and exacerbating disease has also been documented by passive transfer of FIPV-reactive immune serum or purified immunoglobulin to seronegative * Corresponding author. France. cats. Such antibody-sensitized cats develop enhanced disease after challenge with FIPV (39, 53) . This phenomenon of antibody-dependent enhancement (ADE) is thought to occur when virus-antibody immune complexes bind to Fc receptors for immunoglobulin G (IgG; Fc-yR) present on the cell surface of macrophages, the putative target cells of FIPV (34, 43, 45) . Enhanced uptake of virus by macrophages in the presence of subneutralizing concentrations of antibody has been demonstrated in vitro (34) and results in a paradoxical increase in the number of infected cells. A similar phenomenon of increased viral replication in the presence of antibody is believed to occur in vivo, resulting in increased virulence and dissemination of FIPV in sensitized cats.
Previous studies have shown that the spike protein (S), one of three structural proteins of FIPV, is responsible for eliciting virus-neutralizing antibodies (12, 14, 34, 49) . However, when kittens were vaccinated with recombinant vaccinia virus expressing S, nucleocapsid protein (N), or membrane protein (M), ADE was observed after challenge with FIPV only in those kittens vaccinated with the S recombinant (12, 49) . This suggests that epitopes located on S are responsible for mediating both virus neutralization and ADE. Using monoclonal antibodies (MAbs) to FIPV, we have shown that individual epitopes on S can mediate both processes (34 Virus neutralization. Samples of ascites fluid were heat inactivated at 56°C for 30 min. Serial twofold dilutions of MAb were made in Eagle minimum essential medium containing 10% FBS and antibiotics in 96-well, flat-bottom cell culture plates, retaining 50 p.l of each dilution in duplicate wells. An equal volume of medium containing 100 TCID50 of FIPV 79-1146 was added to each well. The plates were incubated at 22°C for 1 h, and then approximately 2 x 104 CRFK cells per well in complete medium were added. The plates were incubated at 37°C for 4 days, and the neutralization titers were recorded as the reciprocals of the highest dilutions of MAbs that completely inhibited cytopathology.
Determination of immunoglobulin subclass. Macrophage cultures were infected with this mixture and incubated at 37°C for 1 h. The inoculum was removed by two washes with PBSS, and cells were incubated in fresh medium for an additional 9.5 h. Cultures were then washed in PBSS, fixed in acetone, and stored at -70°C until used. A similar procedure was used with the mouse macrophage cell line IC-21. Evidence of ADE was determined quantitatively by an increase in the numbers of FIPV-infected macrophages over the number of macrophages infected with virus in the absence of MAb. Virus-infected cells were detected by IFA with FIPV-specific feline serum, followed by fluorescein-conjugated goat anti-cat IgG (Cappel Research Products).
RESULTS
Recognition of FIPV proteins. The three structural proteins of FIPV detected by radioimmunoprecipitation with FIPVspecific antiserum had molecular masses of 205 (S), 45 (N), and 26 to 28 (M) kDa (Fig. 1) . This is in agreement with previous studies (8, 11, 23) . Endo-,-N-acetylglucosaminidase H treatment of FIPV proteins has shown that the doublet seen at 26 and 28 kDa represents the unglycosylated form and glycosylated form of M, respectively (51 A total of 54 MAbs were tested by radioimmunoprecipitation for their viral-protein specificity, with FIPV 79-1146-infected cell lysates. A total of 47 MAbs recognized S, 3 MAbs recognized N, and 4 MAbs recognized M. In some instances, S and M were coprecipitated by a single MAb. Many of the S-specific MAbs, in particular, showed some coprecipitation of M (Fig. 1, lanes 9 and 10) . However, when cell lysates were denatured prior to the addition of MAb, a greater degree of specificity was obtained (Fig. 2) . This was accomplished by denaturing concentrated cell lysates with 4 mM dithiothreitol and 2% SDS before diluting samples and adding MAbs.
MAbs were also tested for their ability to recognize S produced in Vero cells infected with rPV-S by IFA. When S-specific MAbs were used, strong immunofluorescence was observed in localized areas surrounding the focal plaques produced by the poxvirus (Fig. 3A) . Expression of S was indicated by the presence of large, brightly staining, multinucleated syncytia in these areas. When N-or M-specific MAbs were used, both the syncytia and the surrounding infected cells were negative (Fig. 3B) .
Virus neutralization and MAb reactivity with escape mutants. All MAbs were tested for their ability to neutralize virus in a standard virus neutralization assay. A total of 19 of the 54 MAbs neutralized FIPV with titers that ranged from 10 to 20,480 ( Table 1 ). The 19 virus-neutralizing MAbs were all found to be specific for S by radioimmunoprecipitation and strong reactivity with rPV-S.
Each of the neutralizing MAbs was used to select for neutralization-resistant escape mutants of FIPV in order to assess the degree of overlap between the different epitopes involved in neutralization. MAbs that lost their ability to react with a particular escape mutant were grouped together with the MAb that selected for it. This was based on subclass. The apparent IgGl subclass restriction of these 4 MAbs was particularly noticeable with MAb 22A12.10, a member of the larger group of 12 related MAbs in group 3. In contrast to the IgG2a subclass of the other 11 enhancing MAbs in group 3, MAb 22A12.10 was the only member that belonged to the IgGl subclass. A similar difference in subclass in combination with absence of ADE was seen with MAb 24H5.4 compared with the related group 4 MAb 23F8.1. Only one MAb of the IgGl subclass (18H9.1) was enhancing, although it differed from the other four IgGl MAbs in that it was nonneutralizing. MAb 18H9.1 was also the least enhancing of all MAbs tested (34) . A schematic map of enhancing and neutralizing sites on S and their relationship with immunoglobulin subclasses is presented in Fig. 6 . DISCUSSION ADE of infection is believed to be the major cause of vaccine failure for avirulent live (38) to FIPV by itself appears to be a poor indicator of immune status. The presence of neutralizing antibody often leads to enhanced disease rather than protection, even though protected cats most often develop high neutralizing-antibody titers. Immunization studies with recombinant vaccinia virus expressing FIPV proteins have shown that antibodies to S rather than to M or N are responsible for ADE in vivo (49, 50) . Although support for a unique role of S in generating neutralizing antibodies which mediate ADE was also found in vitro (34), a recent study suggests that ADE can be mediated by nonneutralizing antibodies to M as well as S (21) . In order to begin to address some of these apparent discrepancies, further identification of the viral proteins containing neutralizing and enhancing epitopes is needed, along with a better understanding of the relationship between virus neutralization and ADE.
In the present study, 54 MAbs to FIPV were characterized and used to assess their abilities to induce virus neutralization and ADE in cell culture. Only S-specific MAbs were capable of mediating neutralization or ADE. In many in- sured in that study represented about a 2-fold increase in the number of infected cells while the degree of enhancement measured in the present study often approached or exceeded a 100-fold increase (Fig. 4) (15, 16, 19, 25, 46, 47) , it has been most thoroughly studied with dengue virus. ADE of dengue virus infection occurs with either Fc-yRI (26) or Fc-yRII (27) or by linking of virus to a number of non-Fc-yR cell surface molecules (29) . Because of an apparent lack of any single unique signaling function, it has been proposed that binding of dengue virusspecific antibody to the Fc-yR simply enhances the opportunity for antibody-bound virus to reach the cell surface and bind to viral receptors, resulting in increased efficiency of infection (29) .
It seems unlikely, however, that the enhancement seen with FIPV is due only to a greater efficiency of virus interaction with its receptor. The sheer magnitude of the increase in numbers of infected cells suggests an alternate pathway. In some instances, the number of infected cells increased from 55% to nearly 100% in the presence of antibody. Additionally, we were able to infect a low percentage of mouse macrophages with FIPV in the presence of antibody, even though these cells appear to lack any receptor for FIPV at all (Fig. 5) . It seems more likely that an alternative yet highly efficient form of Fc-yR-mediated endocytosis is occurring.
The low number of N-and M-specific MAbs generated does not allow us to make absolute conclusions regarding their observed inability to induce ADE. In addition, even the enhancement seen with S-specific MAbs may not necessarily reflect the full scope of FIPV infection in vivo. Nevertheless, the close association of ADE with virus neutralization and the observed functional differences in immunoglobulin subclass should further extend our understanding of the basic pathogenesis of FIP.
